Cargando…

Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells

Genomic instability is a hallmark of breast cancer, contributes to tumor heterogeneity, and influences chemotherapy resistance. Although Gap 2 and mitotic checkpoints are thought to prevent genomic instability, the role of these checkpoints in breast cancer is poorly understood. Here, we assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bower, Jacquelyn J., Vance, Leah D., Psioda, Matthew, Smith-Roe, Stephanie L., Simpson, Dennis A., Ibrahim, Joseph G., Hoadley, Katherine A., Perou, Charles M., Kaufmann, William K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445620/ https://www.ncbi.nlm.nih.gov/pubmed/28649649 http://dx.doi.org/10.1038/s41523-017-0009-7

Ejemplares similares

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
por: Prat, Aleix, et al.
Publicado: (2015)

Topoisomerase IIα maintains genomic stability through decatenation G(2) checkpoint signaling
por: Bower, Jacquelyn J., et al.
Publicado: (2010)

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status
por: Prat, Aleix, et al.
Publicado: (2014)

Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
por: Kowalewski, Ashley A., et al.
Publicado: (2011)

Targeting Cell Cycle Checkpoint Kinases to Overcome Intrinsic Radioresistance in Brain Tumor Cells
por: Vlatkovic, Tijana, et al.
Publicado: (2022)

Intrinsic checkpoint deficiency during cell cycle re-entry from quiescence
por: Matson, Jacob Peter, et al.
Publicado: (2019)

Cell cycle control, checkpoint mechanisms, and genotoxic stress.
por: Shackelford, R E, et al.
Publicado: (1999)

Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential
por: Namløs, Heidi Maria, et al.
Publicado: (2023)

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
por: Prat, Aleix, et al.
Publicado: (2010)

Prediction of Toxicant-Specific Gene Expression Signatures after Chemotherapeutic Treatment of Breast Cell Lines
por: Troester, Melissa A., et al.
Publicado: (2004)

Loss of cks1 homeostasis deregulates cell division cycle
por: Krishnan, Anand, et al.
Publicado: (2010)

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013)

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
por: Couture, Heather D., et al.
Publicado: (2018)

Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes
por: Serrano-Carbajal, Erandi A., et al.
Publicado: (2020)

Identification of drug targets for the treatment of Basal-like tumors
por: Hoadley, KA, et al.
Publicado: (2005)

Deregulated expression of NKL homeobox genes in T-cell lymphomas
por: Nagel, Stefan, et al.
Publicado: (2019)

Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G(1 )checkpoint function
por: Simpson, Dennis A, et al.
Publicado: (2005)

Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators
por: Uversky, Vladimir N.
Publicado: (2014)

Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer
por: Prat, Aleix, et al.
Publicado: (2014)

EGFR associated expression profiles vary with breast tumor subtype
por: Hoadley, Katherine A, et al.
Publicado: (2007)

Identification of mRNA isoform switching in breast cancer
por: Zhao, Wei, et al.
Publicado: (2016)

Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer
por: Chong, Taryne, et al.
Publicado: (2018)

Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis
por: Hegner, Björn, et al.
Publicado: (2016)

Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer
por: Thorner, Aaron R., et al.
Publicado: (2010)

Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells
por: Fujita, Masatoshi
Publicado: (2006)

γ‐Irradiation Deregulates Cell Cycle Control and Apoptosis in Nevoid Basal Cell Carcinoma Syndrome‐derived Cells
por: Fujii, Katsunori, et al.
Publicado: (1999)

Cell Intrinsic Deregulated ß-Catenin Signaling Promotes Expansion of Bone Marrow Derived Connective Tissue Type Mast Cells, Systemic Inflammation, and Colon Cancer
por: Saadalla, Abdulrahman, et al.
Publicado: (2019)

Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia
por: Nagel, Stefan, et al.
Publicado: (2016)

Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients
por: Kulikowska de Nałęcz, Anna, et al.
Publicado: (2021)

PEG Induces High Expression of the Cell Cycle Checkpoint Gene WEE1 in Embryogenic Callus of Medicago truncatula: Potential Link between Cell Cycle Checkpoint Regulation and Osmotic Stress
por: Elmaghrabi, Adel M., et al.
Publicado: (2017)

Genetic determinants of the molecular portraits of epithelial cancers
por: Xia, Youli, et al.
Publicado: (2019)

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts
por: Diller, Magnus, et al.
Publicado: (2019)

Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
por: Litchfield, Kevin, et al.
Publicado: (2021)

The nature of cell-cycle checkpoints: facts and fallacies
por: Khodjakov, Alexey, et al.
Publicado: (2009)

The cell cycle checkpoint inhibitors in the treatment of leukemias
por: Ghelli Luserna di Rora’, A., et al.
Publicado: (2017)

Tailored therapies based upon tumor subtype biology
por: Perou, CM
Publicado: (2005)

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay
por: Desai, Neelam V., et al.
Publicado: (2018)

A Flexible and Qualitatively Stable Model for Cell Cycle Dynamics Including DNA Damage Effects
por: Jeffries, Clark D., et al.
Publicado: (2012)

Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma
por: Nagel, Stefan, et al.
Publicado: (2015)

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
por: Zaravinos, Apostolos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6obn44qtl1h576p63pfeg6poto